Business Description
SyneuRx International (Taiwan) Corp
ISIN : TW0006575004
Compare
Compare
Traded in other countries / regions
6575.Taiwan IPO Date
2016-01-29Description
SyneuRx International (Taiwan) Corp is a bio-medical company. The company is engaged in the development of drugs for treatment of central nervous system-related disorders, including schizophrenia, depression, and dementia. Its pipeline under clinical development includes SND-11, SND-12, SND-13, which is in Phase IIb/III clinical trial for the treatment of add-on therapy of schizophrenia.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.44 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -12.2 | |||||
| 3-Year EPS without NRI Growth Rate | -11.2 | |||||
| 3-Year FCF Growth Rate | -12.1 | |||||
| 3-Year Book Growth Rate | -33.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.17 | |||||
| Quick Ratio | 6.16 | |||||
| Cash Ratio | 4.8 | |||||
| Days Inventory | 772.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.3 | |||||
| Shareholder Yield % | -6.85 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.77 | |||||
| Operating Margin % | -53293.15 | |||||
| Net Margin % | -64619.8 | |||||
| FCF Margin % | -44860.66 | |||||
| ROE % | -140.14 | |||||
| ROA % | -105.51 | |||||
| ROIC % | -275.6 | |||||
| 3-Year ROIIC % | 300.16 | |||||
| ROC (Joel Greenblatt) % | -379.3 | |||||
| ROCE % | -121.13 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5433.33 | |||||
| PB Ratio | 12.38 | |||||
| Price-to-Tangible-Book | 12.44 | |||||
| EV-to-EBIT | -7.34 | |||||
| EV-to-EBITDA | -7.59 | |||||
| EV-to-Revenue | 4699.23 | |||||
| EV-to-FCF | -10.48 | |||||
| Price-to-Net-Current-Asset-Value | 14.82 | |||||
| Price-to-Net-Cash | 21.17 | |||||
| Earnings Yield (Greenblatt) % | -13.62 | |||||
| FCF Yield % | -8.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SyneuRx International (Taiwan) Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 0.394 | ||
| EPS (TTM) (NT$) | -2.08 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (NT$) | 0 | ||
| 20-Day SMA (NT$) | 16.3 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (NT$) | 16.3 - 16.3 | ||
| Shares Outstanding (Mil) | 135.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SyneuRx International (Taiwan) Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SyneuRx International (Taiwan) Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
SyneuRx International (Taiwan) Corp Frequently Asked Questions
What is SyneuRx International (Taiwan) Corp(ROCO:6575)'s stock price today?
The current price of ROCO:6575 is NT$16.30. The 52 week high of ROCO:6575 is NT$16.30 and 52 week low is NT$16.30.
When is next earnings date of SyneuRx International (Taiwan) Corp(ROCO:6575)?
The next earnings date of SyneuRx International (Taiwan) Corp(ROCO:6575) is .
Does SyneuRx International (Taiwan) Corp(ROCO:6575) pay dividends? If so, how much?
SyneuRx International (Taiwan) Corp(ROCO:6575) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers